Meihua International Medical Technologies Co., Ltd. - MHUA

MHUA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
MHUA	3.3	0.8	20.3	-69.1	-67.2	-63.2	-97.5	-97.5	-97.5	-97.5
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare MHUA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	MHUA
name	Meihua International Medical Technologies Co., Ltd.
price	0.3249
changes percentage	3.3068
change	0.0104
day low	0.31
day high	0.329
year high	1.47
year low	0.25
market cap	8477874
price avg 50	0.46536
price avg 200	0.72848
exchange	NASDAQ
volume	192382
avg volume	958403
open	0.3145
previous close	0.3145
eps	0.37
pe	0.88
earnings announcement	2024-04-12T04:00:00.000+0000
shares outstanding	26093796
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 53.0%

Overall Quarterly Financial Health: 55.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001835615
revenue	97098915	103346341	-6.05
gross profit	33095002	38098477	-13.13
gross profit ratio	0.34	0.37	-7.54
research and development expenses	2753315	2962904	-7.07
operating expenses	18420064	22540979	-18.28
interest income	873439	63725	1270.64
interest expense	250781	194667	28.83
ebitda	15770550	16120959	-2.17
ebitdaratio	0.16	0.16	4.05
operating income	14674938	15568018	-5.74
operating income ratio	0.15	0.15	0.33
net income	11625417	6242969	86.22
net income ratio	0.12	0.06	98.20
eps	0.49	0.27	81.48

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 97 million in 2023 from 103 million in 2022 representing a change of -6.05%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 18 million in 2023 from 23 million in 2022 representing a change of -18.28%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to 0.49 in 2023 from 0.49 in 2022 representing a change of 81.48%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 33 million in 2023 from 38 million in 2022 representing a change of -13.13%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 3 million in 2023 from 3 million in 2022 representing a change of -7.07%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 16 million in 2023 from 16 million in 2022 representing a change of -2.17%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 15 million in 2023 from 16 million in 2022 representing a change of -5.74%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 12 million in 2023 from 6 million in 2022 representing a change of 86.22%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001835615
revenue	22671849	22671849	0.0
gross profit	7567697	7567697	0.0
gross profit ratio	0.33	0.33	0.0
research and development expenses	729973	729973	0.0
operating expenses	4621691	4621691	0.0
interest income	292670	0	NaN
interest expense	129291	0	NaN
ebitda	3091704	3091704	0.0
ebitdaratio	0.14	0.14	0.0
operating income	2946006	2946006	0.0
operating income ratio	0.13	0.13	0.0
net income	2358295	2358295	0.0
net income ratio	0.1	0.1	0.0
eps	0.09	0.09	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001835615
total assets	171915272	163577579	5.10
total liabilities	25077450	24898499	0.72
total equity	146837822	138679080	5.88
cash and cash equivalents	16926878	26736700	-36.69
short term investments	0	0	NaN
long term investments	6131941	6669655	-8.06
total current assets	132237053	135319155	-2.28
total non current assets	39678219	28258424	40.41
total current liabilities	25072858	24173567	3.72
total non current liabilities	4592	724932	-99.37
common stock	11970	11970	0.00
retained earnings	94635889	83330239	13.57
total debt	7331134	6814360	7.58

Overall Score of Annual Balance Sheet

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 172 million in 2023 from 164 million in 2022 representing a change of 5.1%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 147 million in 2023 from 139 million in 2022 representing a change of 5.88%. This indicates an increase in shareholders' equity.

  Retained Earnings: Retained Earnings increased to 95 million in 2023 from 83 million in 2022 representing a change of 13.57%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 25 million in 2023 from 25 million in 2022 representing a change of 0.72%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 17 million in 2023 from 27 million in 2022 representing a change of -36.69%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 132 million in 2023 from 135 million in 2022 representing a change of -2.28%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 25 million in 2023 from 24 million in 2022 representing a change of 3.72%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 7 million in 2023 from 7 million in 2022 representing a change of 7.58%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001835615
total assets	179162816	179162816	0.0
total liabilities	29590466	29590466	0.0
total equity	149572350	149572350	0.0
cash and cash equivalents	18490635	18490635	0.0
short term investments	0	0	NaN
long term investments	8641607	8641607	0.0
total current assets	141313649	141313649	0.0
total non current assets	37849167	37849167	0.0
total current liabilities	29590466	29590466	0.0
total non current liabilities	0	0	NaN
common stock	13046	13046	0.0
retained earnings	115338106	115338106	0.0
total debt	11766839	11766839	0.0

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001835615
net change in cash	-9809822	18587424	-152.78
operating cash flow	2275750	-9163038	124.84
free cash flow	-2410832	-11861767	79.68
capital expenditure	-4686582	-2698729	-73.66
depreciation and amortization	470993	563461	-16.41
deferred income tax	-370475	0	NaN
stock based compensation	0	0	NaN
accounts payables	185902	-3371275	105.51
inventory	-528635	35027	-1609.22
acquisitions net	0	658456	-100.00
investments in property plant and equipment	-1182699	-2698729	56.18
net cash used for investing activites	-12458698	-8620292	-44.53
debt repayment	706125	2080546	-66.06
common stock issued	0	34529644	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	706125	37245500	-98.10
cash at end of period	16926878	26736700	-36.69
accounts receivables	-14015900	-7121889	-96.80
cash at beginning of period	26736700	8149276	228.09

Overall Score of Annual Cashflow Statement

0.83 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -10 million in 2023 from 19 million in 2022 representing a change of -152.78%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 2 million in 2023 from -9 million in 2022 representing a change of 124.84%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -2 million in 2023 from -12 million in 2022 representing a change of 79.68%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -5 million in 2023 from -3 million in 2022 representing a change of -73.66%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 3 million in 2022 representing a change of 105.51%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -14 million in 2023 from -7 million in 2022 representing a change of -96.8%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001835615
operating cash flow	507900	507900	0.00
free cash flow	502689	502689	0.00
capital expenditure	-10419	-5211	-99.94
depreciation and amortization	145900	145900	0.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-4095583	-4095583	0.00
accounts payables	1168462	0	NaN
inventory	245604	245604	0.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-5211	-5211	0.00
net cash used for investing activites	-2712430	-2712430	0.00
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	3067201	3067201	0.00
net change in cash	1563757	781879	100.00
cash at end of period	18490635	781879	2264.90
cash at beginning of period	16926878	0	NaN

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2 million in 2024Q2 from 1 million in 2024Q1 representing a change of 100.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -99.94%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Accounts Payables: The absolute value of Accounts Payables increased to 1 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	4.06	4.41	-8.12
net income per share	0.49	0.27	82.10
operating cash flow per share	0.1	-0.39	124.29
free cash flow per share	-0.1	-0.51	80.12
cash per share	0.71	1.14	-38.09
book value per share	6.13	5.92	3.54
tangible book value per share	5.97	5.9	1.15
shareholders equity per share	6.11	5.9	3.60
interest debt per share	0.32	0.3	5.78
market cap	35431228.12	193843643.04	-81.72
enterprise value	25835484.12	173921303.04	-85.15
pe ratio	3.05	31.05	-90.18
price to sales ratio	0.36	1.88	-80.55
pocfratio	15.57	-21.15	173.60
pfcf ratio	-14.7	-16.34	10.07
pb ratio	0.24	1.4	-82.75
ptb ratio	0.24	1.4	-82.75
ev to sales	0.27	1.68	-84.19
enterprise value over ebitda	1.64	10.79	-84.82
ev to operating cash flow	11.35	-18.98	159.81
ev to free cash flow	-10.72	-14.66	26.91
earnings yield	0.33	0.03	918.79
free cash flow yield	-0.07	-0.06	-11.19
debt to equity	0.05	0.05	1.55
debt to assets	0.04	0.04	2.37
net debt to ebitda	-0.61	-1.24	50.76
current ratio	5.27	5.6	-5.78
interest coverage	58.52	79.97	-26.83
income quality	0.2	-1.48	113.24
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.08	0.13	-36.20
research and ddevelopement to revenue	0.03	0.03	-1.09
intangibles to total assets	0.02	0.0	648.79
capex to operating cash flow	2.06	-0.29	799.22
capex to revenue	0.05	0.03	84.83
capex to depreciation	9.95	4.79	107.75
stock based compensation to revenue	0	0	NaN
graham number	8.17	5.95	37.35
roic	0.07	0.06	20.80
return on tangible assets	0.07	0.04	80.76
graham net net	2.81	3.02	-6.94
working capital	107164195	111145588	-3.58
tangible asset value	142921905	138181480	3.43
net current asset value	107159603	110420656	-2.95
invested capital	119918167	120401235	-0.40
average receivables	95245427.5	88756390	7.31
average payables	15959097	18538603	-13.91
average inventory	1369631.5	1186715.5	15.41
days sales outstanding	373.87	321.51	16.29
days payables outstanding	90.23	90.04	0.21
days of inventory on hand	9.22	6.28	46.93
receivables turnover	0.98	1.14	-14.01
payables turnover	4.05	4.05	-0.21
inventory turnover	39.58	58.15	-31.94
roe	0.08	0.05	75.77
capex per share	0.2	0.12	69.82

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 3.05 on 2023-12-31 from 31.05 on 2022-12-31, representing a change of -90.18%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 5.27 on 2023-12-31 from 5.60 on 2022-12-31, representing a change of -5.78%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2023-12-31 from 0.05 on 2022-12-31, representing a change of 1.55%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
MHUA
calendar year	2024	2024	NaN
revenue per share	0.82	0.82	0.00
net income per share	0.09	0.09	0.00
operating cash flow per share	0.02	0.02	0.00
free cash flow per share	0.02	0.02	0.00
cash per share	0.67	0.67	0.00
book value per share	5.39	5.39	0.00
tangible book value per share	5.37	5.37	0.00
shareholders equity per share	5.39	5.39	0.00
interest debt per share	0.43	0.42	1.10
market cap	27550434.47	20253592.31	36.03
enterprise value	20826638.47	13529796.31	53.93
pe ratio	2.92	2.15	36.03
price to sales ratio	1.22	0.89	36.03
pocfratio	54.24	39.88	36.03
pfcf ratio	54.81	40.29	36.03
pb ratio	0.18	0.14	36.03
ptb ratio	0.18	0.14	36.03
ev to sales	0.92	0.6	53.93
enterprise value over ebitda	6.74	4.38	53.93
ev to operating cash flow	41.01	26.64	53.93
ev to free cash flow	41.43	26.91	53.93
earnings yield	0.09	0.12	-26.49
free cash flow yield	0.02	0.02	-26.49
debt to equity	0.08	0.08	0.00
debt to assets	0.07	0.07	0.00
net debt to ebitda	-2.17	-2.17	0.00
current ratio	4.78	4.78	0.00
interest coverage	22.79	0	NaN
income quality	0.22	0.22	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.08	0.08	0.00
research and ddevelopement to revenue	0.03	0.03	0.00
intangibles to total assets	0.0	0.0	0.00
capex to operating cash flow	0.02	0.01	99.94
capex to revenue	0.0	0.0	99.94
capex to depreciation	0.07	0.04	99.94
stock based compensation to revenue	0	0	NaN
graham number	3.21	3.21	0.00
roic	0.01	0.01	0.00
return on tangible assets	0.01	0.01	0.00
graham net net	2.37	2.37	0.00
working capital	111723183	111723183	0.00
tangible asset value	149119689	149119689	0.00
net current asset value	111723183	111723183	0.00
invested capital	120365415	120365415	0.00
average receivables	101891922	100675569.5	1.21
average payables	15863347	15842688	0.13
average inventory	1092314	1354769.5	-19.37
days sales outstanding	404.48	404.48	0.00
days payables outstanding	94.52	94.52	0.00
days of inventory on hand	6.51	6.51	0.00
receivables turnover	0.22	0.22	0.00
payables turnover	0.95	0.95	0.00
inventory turnover	13.83	13.83	0.00
roe	0.02	0.02	0.00
capex per share	0.0	0.0	99.94

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 4.78 on 2024-06-30 Q2 from 4.78 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 2.92 on 2024-06-30 Q2 from 2.15 on 2024-03-31 Q1, representing a change of 36.03%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.08 on 2024-06-30 Q2 from 0.08 on 2024-03-31 Q1, representing a change of 0.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None